PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 167 filers reported holding PRECIGEN INC in Q3 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $174,062 | -30.3% | 164,209 | 0.0% | 0.01% | -35.3% |
| Q4 2022 | $249,598 | -28.3% | 164,209 | 0.0% | 0.02% | -32.0% |
| Q3 2022 | $348,000 | +21.3% | 164,209 | -23.3% | 0.02% | +25.0% |
| Q2 2022 | $287,000 | -36.5% | 214,209 | 0.0% | 0.02% | -23.1% |
| Q1 2022 | $452,000 | -43.1% | 214,209 | 0.0% | 0.03% | -45.8% |
| Q4 2021 | $795,000 | -25.6% | 214,209 | 0.0% | 0.05% | -32.4% |
| Q3 2021 | $1,069,000 | -23.5% | 214,209 | 0.0% | 0.07% | -24.5% |
| Q2 2021 | $1,397,000 | +315.8% | 214,209 | +339.4% | 0.09% | +261.5% |
| Q1 2021 | $336,000 | -32.4% | 48,755 | 0.0% | 0.03% | -36.6% |
| Q4 2020 | $497,000 | +190.6% | 48,755 | 0.0% | 0.04% | +173.3% |
| Q3 2020 | $171,000 | -29.6% | 48,755 | 0.0% | 0.02% | -34.8% |
| Q2 2020 | $243,000 | +74.8% | 48,755 | +19.3% | 0.02% | +43.8% |
| Q1 2020 | $139,000 | – | 40,881 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |